A Phase I Study of Oral MEK162 in Japanese Patients With Advanced Solid Tumors
Clinical trial NCT01469130 · COMPLETED
Trial details
- NCT number
- NCT01469130
- Sponsor
- Array Biopharma, now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-04-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.